Skip to main content
. 2007 Nov 15;2:41. doi: 10.1186/1748-717X-2-41

Table 4.

Mean percent volume of OAR receiving various dose levels for N2-3 and/or T4 patients (upper limit of fields at L5-S1) for a 59.4 Gy treatment

Mean volume receiving above threshold dose (%)
Organ Threshold dose (Gy) A B C D

Bladder 30 100 88.6* (76–100) 84.9* (71–99) 77.0* (68–84)
40 100 60.2* (43–74) 52.5* (39–70) 39.0* (30–54)
Genitalia/perineum 30 87.0 (60–100) 64.4 (26–93) 46.2* (26–68) 32.8* (20–53)
40 85.1 (56–99) 25.9* (2–43) 9.8* (1–26) 7.4* (0–26)
Small bowel 30 64.4 (48–89) 43.6* (38–52) 43.0* (37–50) 45.8 (39–55)
40 62.1 (45–87) 26.5* (21–30) 25.8* (19–30) 28.3* (20–35)
Iliac crests 10 59.9 (57–63) 52.2* (45–57) 51.4* (45–56) 56.0 (47–60)
20 50.2 (47–54) 33.0* (30–37) 32.8* (30–37) 34.3* (30–38)
Femoral heads 45 29.9 (21–39) 15.7* (8–21) 8.8* (6–14) 14.6* (11–17)

†Mean in % (range).

* denotes statistically significant p values (p < 0.05) as compared with arm A.